Research Article

Vessel Wall-Derived Mesenchymal Stromal Cells Share Similar Differentiation Potential and Immunomodulatory Properties with Bone Marrow-Derived Stromal Cells

Figure 5

Relative expression levels of selected genes in MSCs derived from bone marrow and saphenous vein in resting and stimulated cells. Mesenchymal stromal cells were treated with 100 ng/ml LPS, 25 μg/ml PolyI:C, 100 ng/ml TNFα, 10 ng/ml IL-1β, or 10 ng/ml IFNγ for 12 and 24 hours as described in Methods. Relative levels of mRNA were measured in triplicates by qPCR, and fold changes in the gene expression were calculated from the ratio of expression levels in treated and untreated cells as ( in both cell types).